Skip to main content
Clinical Trials/CTIS2024-515811-22-00
CTIS2024-515811-22-00
Active, not recruiting
Phase 1

Exploratory study on the impact of different doses and route of administration of exogenous progesterone in artificial endometrial preparation cycles on endometrial structure and function - 1901-VLC-014-E

Ivi Valencia S.L.0 sites108 target enrollmentJune 26, 2024

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Ivi Valencia S.L.
Enrollment
108
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 26, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
Ivi Valencia S.L.

Eligibility Criteria

Inclusion Criteria

  • All women with no history of infertility who agree to participate in the study: 1\. Informed consent form (ICF) dated and signed. 2\. Age: 18\-35 years old , both inclusive 3\. Regular menstrual cycles (between 22 and 35 days) 4\. In good health and not suffering from any mental or medical condition(s) that would preclude participation in the study

Exclusion Criteria

  • Subjects who meet one or more of the following will not be considered eligible to participate in the pilot study: 1\.Simultaneous participation in other clinical studies that, at the researcher's criteria, could interfere with the results of this study. 2\.Taking contraceptives in the three months prior to signing informed consent. 3\.Presence of uterine pathology (submucosal or intramural myomas \>4 cm deforming cavity, endometrial polyps or müllerian anomalies) or adnexal pathology (communicating hydrosalpinx). 4\.Background of thrombosis, breast cancer, systemic diseases. 5\.Those unable to comprehend the investigational nature of the proposed study.

Outcomes

Primary Outcomes

Not specified

Similar Trials